SPS
CGEM icon

Susquehanna Portfolio Strategies’s Cullinan Oncology CGEM Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.32M Hold
233,842
– – 0.05% 384
2025
Q4 		$2.42M Buy
233,842
+109,311
+88% +$986K 0.04% 457
2025
Q3 		$738K Buy
+124,531
New +$912K 0.01% 747

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Susquehanna Portfolio Strategies's CGEM Position: Q1 2026 in Review

Susquehanna Portfolio Strategies held its Cullinan Oncology (CGEM) position steady in Q1 2026 at 233,842 shares worth $3.32M. The position accounts for 0.05% of the portfolio, ranked #384.

Susquehanna Portfolio Strategies first reported a position in CGEM in Q3 2025 and has held it in 3 quarters since. 174 funds tracked by Wall St. Rank hold CGEM as of Q1 2026.

  • Susquehanna Portfolio Strategies held 233,842 shares of Cullinan Oncology worth $3.32M as of Q1 2026.
  • Susquehanna Portfolio Strategies left its Cullinan Oncology share count unchanged in Q1 2026.
  • Cullinan Oncology made up 0.05% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #384 holding.
  • Susquehanna Portfolio Strategies first reported a position in Cullinan Oncology in Q3 2025 and has held it in 3 quarters since.
  • 174 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.